Inspire Medical Systems (NYSE: INSP) reported Q1 EPS of $0.10, $0.34 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $201.3 million versus the consensus estimate of $195.2 million.

GUIDANCE:

Inspire Medical Systems sees FY2025 EPS of $2.20-$2.30, versus prior guidance of $2.10-$2.20 and the consensus of $2.16. Inspire Medical Systems sees FY2025 revenue of $940-955 million, versus the consensus of $949.2 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.